Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Different types of fibroblasts play various roles in kidney repair and aging, and may affect chronic kidney disease outcomes.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

Combining different treatments like fillers, collagen stimulators, botulinum toxin, and energy devices gives better facial rejuvenation results.

Stem cell therapies show promise for hair regrowth in androgenetic alopecia.

Perifollicular elastolysis is poorly understood, with limited treatment options and inconsistent results.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

Acupuncture may help with hair regrowth in alopecia areata, but more research is needed.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

Injectable platelet-rich fibrin improves hair growth and reduces hair loss in women.

JAK inhibitors effectively regrow hair in children with alopecia areata and are safe to use.

Using a carbon dioxide laser and platelet-rich plasma together can effectively restore hair and patients are generally satisfied with the results.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

A certain mutation in the fetal alpha 5-reductase gene is linked to a higher risk of late miscarriage.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Certain cancer drugs interact with skin bacteria to cause acne-like rashes.

Choose FDA-cleared red light therapy devices and follow guidelines for safe use.

Low-dose rapamycin microdepots can help regrow hair by activating certain cell processes.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Naringin may help treat atopic dermatitis by reducing inflammation and improving the skin barrier.

Post-drug syndromes are often overlooked, and better systems and education are needed to improve drug safety.

Current drug safety systems fail to detect long-term side effects, needing improvements to protect health and trust.

Current drug safety systems fail to detect long-term side effects, leading to preventable health issues.

Exosome-based treatments may improve skin and hair issues, but more research is needed for safety and effectiveness.

Advancements in gene therapy, stem cells, and biomaterials show promise for reducing scarring in wound healing, but face clinical challenges.

Exosome-based therapies show promise for treating alopecia areata but need more research.

Both Unani treatments effectively reduced hair shedding in Telogen Effluvium.

Air pollution harms skin health and can worsen skin diseases.

Exosome-based therapies in dermatology show promise but face challenges in standardization, regulation, and safety.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.